These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6855795)

  • 41. [Study of the possibilities of using a short-term test system in vitro for detection of potential mutagens (carcinogens)].
    Domshlak MG; Sanotskiĭ IV; Serebrianyĭ AM
    Gig Tr Prof Zabol; 1989; (11):47-9. PubMed ID: 2515120
    [No Abstract]   [Full Text] [Related]  

  • 42. Mutagenicity screening/in vitro testing--the end of an era; animal and human studies--the direction for the future.
    Legator MS; Harper BL
    Ann N Y Acad Sci; 1988; 534():833-44. PubMed ID: 3291729
    [No Abstract]   [Full Text] [Related]  

  • 43. Carcinogenesis. Testing times for the tests.
    Hay A
    Nature; 1991 Apr; 350(6319):555-6. PubMed ID: 2017254
    [No Abstract]   [Full Text] [Related]  

  • 44. Mutagenic activity of carcinogens detected in transgenic rodent mutagenicity assays at dose levels used in chronic rodent cancer bioassays.
    Schmezer P; Eckert C; Liegibel UM; Zelezny O; Klein RG
    Mutat Res; 1998 Sep; 405(2):193-8. PubMed ID: 9748572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of experimental parameters in an S9 /human leukocyte SCE test with cyclophosphamide.
    Madle S
    Mutat Res; 1981 Oct; 85(5):347-56. PubMed ID: 7300852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of black tea theafulvins on aflatoxin B(1) mutagenesis in the Ames test.
    Catterall F; Copeland E; Clifford MN; Ioannides C
    Mutagenesis; 2003 Mar; 18(2):145-50. PubMed ID: 12621070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies.
    Benigni R; Bossa C; Tcheremenskaia O; Battistelli CL; Giuliani A
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():35-8. PubMed ID: 25813724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic activation of chemicals to mutagenic carcinogens by human hepatoma microsomal extracts in Chinese hamster ovary cells (in vitro).
    Darroudi F; Natarajan AT
    Mutagenesis; 1993 Jan; 8(1):11-5. PubMed ID: 8383795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carcinogen-DNA adducts in mutagenesis assays.
    Grunberger D; Santella RM; Weinstein IB
    Science; 1981 Sep; 213(4514):1411-2. PubMed ID: 7268446
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of carcinogenic substances by means of short-term tests in bacteria.
    Quillardet P; McGregor D
    IARC Sci Publ; 1999; (146):487-97. PubMed ID: 10353400
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of mutations in transgenic animal models: BigBlue and Muta Mouse.
    Schmezer P; Eckert C
    IARC Sci Publ; 1999; (146):367-94. PubMed ID: 10353395
    [No Abstract]   [Full Text] [Related]  

  • 52. Fluorescence-based recombination assay for sensitive and specific detection of genotoxic carcinogens in human cells.
    Ireno IC; Baumann C; Stöber R; Hengstler JG; Wiesmüller L
    Arch Toxicol; 2014 May; 88(5):1141-59. PubMed ID: 24671466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Towards an improved micronucleus test: studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene.
    Salamone M; Heddle J; Stuart E; Katz M
    Mutat Res; 1980 Oct; 74(5):347-56. PubMed ID: 6782470
    [No Abstract]   [Full Text] [Related]  

  • 54. Micronuclei induced during meiosis by ethyl methanesulfonate, cyclophosphamide and dimethylbenzanthracene in male rats.
    Lähdetie J
    Mutat Res; 1983 Jun; 120(4):257-60. PubMed ID: 6406884
    [No Abstract]   [Full Text] [Related]  

  • 55. The screening, diagnosis and evaluation of genotoxic agents with batteries of bacterial tests.
    Quillardet P; Hofnung M
    Mutat Res; 1988; 205(1-4):107-18. PubMed ID: 3285183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of in vivo-like concentrations of chemicals for validation of in vitro short-term genotoxicity assays--an in vivo equivalent dose concept.
    Dashwood RH; Combes RD
    Mutagenesis; 1987 Jul; 2(4):249-51. PubMed ID: 3325753
    [No Abstract]   [Full Text] [Related]  

  • 57. The detection of environmental mutagens and potential carcinogens.
    Ames BN
    Cancer; 1984 May; 53(10):2034-40. PubMed ID: 6367933
    [No Abstract]   [Full Text] [Related]  

  • 58. A paradigm for determining the relevance of short-term assays: application to oxidative mutagenesis.
    Rosenkranz H
    Mutat Res; 2002 Oct; 508(1-2):21-7. PubMed ID: 12379457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term carcinogenesis and mutagenesis bioassays of unregulated automotive emissions.
    Huisingh JL
    Bull N Y Acad Med; 1981 May; 57(4):251-62. PubMed ID: 6164425
    [No Abstract]   [Full Text] [Related]  

  • 60. Is there a continuing role for the intraperitoneal injection route of exposure in short-term rodent genotoxicity assays?
    Ashby J
    Mutat Res; 1985 Jun; 156(3):239-43. PubMed ID: 4000180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.